Department of Pharmacology & Toxicology

Philippe Vangrieken
PhD Student

Perinatology Research, preeclampsia


p.vangrieken@maastrichtuniversity.nl
+31 43 3881409
4.232

Philippe Vangrieken was born on April 29 1992 in Lommel, Belgium. In 2011 he started the Bachelor program Biomedical Sciences at Maastricht University and enrolled in the Master’s program Biomedical Sciences in 2014 at the Transnational University Limburg (Maastricht University and University Hasselt). During his Master internships he focused on the pregnancy specific disease preeclampsia and how the placenta is involved in this pathology. He also illustrated how the placenta can be used to better understand the etiopathogenesis and progression of this disease. During the first year of his master, he did an internship at the Department of Obstetrics and Gynecology at the azM in Maastricht where he set up a collaboration with the Department of Anatomy & Embryology. During this internship he designed a histological classification system to grade placental maturity for pathological placentas. During his second master internship at the Department of Pharmacology & Toxicology at the University of Maastricht, he collaborated with the department of Obstetrics and Gynecology. In this period he set up an in vitro system for preeclampsia opening avenues to test nutritional interventions aimed at treating or preventing preeclampsia. During his master Philippe was also accepted for the placenta Biology course at the Centre for Trophoblast Research at Cambridge University followed by a summer internship at the Perinatology Research Branch at Yale University, Detroit. After graduating in 2016, he was granted a PhD position through the NWO NUTRIM Graduate Program at the Department of Pharmacology & Toxicology at Maastricht University. In September 2016 he started as a PhD fellow investigating the etiology and treatment of preeclampsia.

Associated Projects

Antioxidant networks

Antioxidant networks in health and disease More »

Transgenerational effects

Paternal and maternal exposure to genotoxins and health risks in their offspring More »